Published in Curr Top Microbiol Immunol on January 01, 2010
VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash. J Neurol Sci (2013) 2.00
Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis (2011) 1.17
Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev (2013) 1.06
Herpes simplex virus and varicella zoster virus, the house guests who never leave. Herpesviridae (2012) 1.04
Orbital apex syndrome associated with herpes zoster ophthalmicus. Clin Ophthalmol (2011) 1.02
Frequency and abundance of alphaherpesvirus DNA in human thoracic sympathetic ganglia. J Virol (2014) 1.00
Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization. J Infect Dis (2011) 0.96
An immunocompetent patient with a vesicular rash and neurological symptomatology. Case Rep Med (2013) 0.91
Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models. J Neurovirol (2011) 0.91
Varicella zoster virus infection. Nat Rev Dis Prim (2015) 0.90
Varicella zoster virus vasculopathy: clinical features and pathogenesis. J Neurovirol (2013) 0.89
Subclinical reactivation of varicella zoster virus in all stages of HIV infection. J Neurol Sci (2011) 0.88
Effect of time delay after necropsy on analysis of simian varicella-zoster virus expression in latently infected ganglia of rhesus macaques. J Virol (2010) 0.87
Varicella zoster virus pneumonitis and brainstem encephalitis without skin rash in an immunocompetent adult. Open Forum Infect Dis (2014) 0.86
Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin. Gene Ther (2014) 0.83
Varicella zoster vaccines and their implications for development of HSV vaccines. Virology (2013) 0.83
Search for varicella zoster virus DNA in saliva of healthy individuals aged 20-59 years. J Med Virol (2013) 0.82
A woman with acute headache and sacral dermatomal numbness. J Clin Virol (2010) 0.81
Use of Saliva to Identify Varicella Zoster Virus Infection of the Gut. Clin Infect Dis (2015) 0.79
Extensive VZV Encephalomyelitis without Rash in an Elderly Man. Case Rep Neurol Med (2014) 0.79
Simian varicella virus open reading frame 63/70 expression is required for efficient virus replication in culture. J Neurovirol (2011) 0.78
Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. J Multidiscip Healthc (2016) 0.75
Decreased HHV-6 IgG in Alzheimer's Disease. Front Neurol (2017) 0.75
Clinical Reasoning: A 57-year-old woman with ataxia and oscillopsia: Varicella-zoster encephalitis. Neurology (2016) 0.75
Alphaherpesvirus DNA replication in dissociated human trigeminal ganglia. J Neurovirol (2016) 0.75
Severe headache with eye involvement from herpes zoster ophthalmicus, trigeminal tract, and brainstem nuclei. Case Rep Radiol (2015) 0.75
Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis. Curr Clin Microbiol Rep (2016) 0.75
Varicella Zoster Virus and Giant Cell Arteritis. J Infect Dis (2016) 0.75
Zeroing in on zoster: A tale of many disorders produced by one virus. J Neurol Sci (2015) 0.75
Thoracic spondylitis induced myelopathy combined with herpetic neuralgia. Korean J Anesthesiol (2013) 0.75
Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo. PLoS Pathog (2015) 0.75
THE JEREMIAH METZGER LECTURE VARICELLA ZOSTER VIRUS: FROM OUTSIDE TO INSIDE. Trans Am Clin Climatol Assoc (2016) 0.75
A Rare Presentation of Cranial Polyneuropathy Without Rash Caused by Varicella Zoster Virus. Med Arch (2017) 0.75
Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology (1996) 4.02
Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis (2008) 3.52
Zoster sine herpete, a clinical variant. Ann Neurol (1994) 2.84
Zoster sine herpete. Br Med J (1958) 2.83
Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol (2004) 2.51
Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med (1992) 2.25
HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci (2005) 2.13
Facial palsy and infection: the unfolding story. Clin Infect Dis (1992) 2.08
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 5-1995. A 73-year-old man with focal brain lesions and peripheral-nerve disease. N Engl J Med (1995) 1.88
Varicella zoster virus-associated focal vasculitis without herpes zoster: recovery after treatment with acyclovir. Neurology (1998) 1.72
Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol (2008) 1.71
Course and outcome of acute cerebellar ataxia. Ann Neurol (1994) 1.67
Varicella-zoster virus myelitis: an expanding spectrum. Neurology (1994) 1.53
Rapid diagnosis of varicella zoster virus infection in acute facial palsy. Neurology (1998) 1.52
Ophthalmic zoster sine herpete. J R Soc Med (2000) 1.43
VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology (2007) 1.41
Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis (1986) 1.28
Recurrent varicella zoster virus myelopathy. J Neurol Sci (2008) 1.26
Varicella zoster-associated neurologic disease without skin lesions. Arch Neurol (1989) 1.26
Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation. J Neurovirol (1996) 1.25
Herpes zoster in children. J Am Acad Dermatol (1998) 1.25
Rapidly progressive outer retinal necrosis caused by varicella zoster virus in a patient infected with human immunodeficiency virus. Clin Infect Dis (1996) 1.22
An unusual cause of trigeminal-distribution pain and tumour. Lancet Neurol (2003) 1.21
Preherpetic neuralgia. Neurology (1991) 1.20
Ramsay Hunt syndrome in children. Ann Neurol (2000) 1.19
The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus. J Neurol Sci (1998) 1.17
Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman. J Neurovirol (2009) 1.07
Intrathecal synthesis of IgG antibodies to varicella-zoster virus in two cases of acute aseptic meningitis syndrome with no cutaneous lesions. J Med Virol (1985) 1.07
Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete. J Med Virol (1998) 1.07
Aseptic meningitis due to varicella-zoster virus: serum antibody levels and local synthesis of specific IgG, IgM, and IgA. J Infect Dis (1987) 1.04
Acute cerebellar ataxia in a 41 year old woman. Lancet Neurol (2006) 1.02
Varicella zoster virus cerebellitis in a 66-year-old patient without herpes zoster. Lancet (2006) 1.01
Varicella zoster virus transverse myelitis without cutaneous rash. Am J Med (1990) 1.00
Varicella-zoster virus acquired at 4 months of age reactivates at 24 months and causes encephalitis. J Pediatr (2002) 1.00
In vivo testing confirms a blunting of the human cell-mediated immune mechanism during space flight. J Leukoc Biol (1992) 0.98
Acute simian varicella infection. Clinical, laboratory, pathologic, and virologic features. Lab Invest (1992) 0.97
Fulminant disseminated Varicella Zoster virus infection without skin involvement. J Clin Virol (2002) 0.95
Zoster sine herpete causing acute trigeminal neuralgia. Lancet (1970) 0.95
Herpes zoster sine herpete presenting with hyphema. Ocul Immunol Inflamm (2000) 0.94
Acute retinal necrosis after chickenpox in a patient with acquired immunodeficiency syndrome. Arch Ophthalmol (1993) 0.93
Profound cerebrospinal fluid pleocytosis and Froin's Syndrome secondary to widespread necrotizing vasculitis in an HIV-positive patient with varicella zoster virus encephalomyelitis. J Neurol Sci (1998) 0.92
Detection of antibodies to varicella-zoster virus proteins in sera from the elderly. Gerontology (1988) 0.91
Zoster sine herpete causing encephalomyelitis. Ital J Neurol Sci (1987) 0.91
Detecting varicella-zoster virus DNA in iridocyclitis using polymerase chain reaction: a case of zoster sine herpete. Arch Ophthalmol (1995) 0.90
Intrathecal synthesis of virus-specific oligoclonal IgG, IgA and IgM antibodies in a case of varicella-zoster meningoencephalitis. J Neurol Sci (1983) 0.89
Ophthalmic zoster sine herpete presenting as oculomotor palsy after marrow transplantation for acute myeloid leukemia. Haematologica (2005) 0.88
Fatal massive hepatic necrosis from varicella-zoster hepatitis. Am J Gastroenterol (1980) 0.88
Pre-eruptive varicella cerebellitis confirmed by PCR. Pediatr Neurol (1995) 0.86
Herpes zoster meningoencephalitis without rash: varicella zoster virus DNA in CSF. J Neurol Neurosurg Psychiatry (1995) 0.86
Disciform keratitis: a case of herpes zoster sine herpete. Am J Ophthalmol (1997) 0.85
Triggering of delayed-onset postherpetic neuralgia. Lancet (1998) 0.84
Retinal periphlebitis as zoster sine herpete. Arch Ophthalmol (2001) 0.83
Polyneuritis cranialis due to varicella-zoster virus in the absence of rash. Neurology (1995) 0.82
Viral reactivation as a cause of unexplained fever in patients with progressive metastatic breast cancer. Cancer Immunol Immunother (1990) 0.80
[A case of zoster sine herpete with involvement of the unilateral IX, X and XI cranial and upper cervical nerves]. Rinsho Shinkeigaku (1999) 0.79
Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol (2009) 4.11
Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis (2008) 3.52
Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol (2011) 2.82
Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol (2004) 2.51
Two patients with unusual forms of varicella-zoster virus vasculopathy. N Engl J Med (2002) 2.46
VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash. J Neurol Sci (2013) 2.00
Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin (2008) 1.99
Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. PLoS Pathog (2009) 1.82
Clinical and molecular pathogenesis of varicella virus infection. Viral Immunol (2003) 1.67
Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia. J Virol (2009) 1.63
Varicella-zoster virus transcriptome in latently infected human ganglia. J Virol (2010) 1.51
Herpesvirus infections of the nervous system. Nat Clin Pract Neurol (2007) 1.48
Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain (2002) 1.44
Varicella zoster virus vasculopathy: a treatable form of rapidly progressive multi-infarct dementia after 2 years' duration. J Neurol Sci (2012) 1.39
Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature. J Neurol Sci (2010) 1.38
Varicella-zoster virus infection of differentiated human neural stem cells. J Virol (2011) 1.34
VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy. Neurology (2005) 1.33
Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J Neurovirol (2003) 1.30
The protean manifestations of varicella-zoster virus vasculopathy. J Neurovirol (2002) 1.28
Recurrent varicella zoster virus myelopathy. J Neurol Sci (2008) 1.26
Neuronal localization of simian varicella virus DNA in ganglia of naturally infected African green monkeys. Virus Genes (2004) 1.26
Disseminated simian varicella virus infection in an irradiated rhesus macaque (Macaca mulatta). J Virol (2006) 1.24
An unusual cause of trigeminal-distribution pain and tumour. Lancet Neurol (2003) 1.21
Varicella zoster virus infection of highly pure terminally differentiated human neurons. J Neurovirol (2012) 1.20
Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis (2011) 1.17
Rapid and sensitive detection of 68 unique varicella zoster virus gene transcripts in five multiplex reverse transcription-polymerase chain reactions. J Virol Methods (2009) 1.17
Differential gene expression in human cerebrovascular malformations. Neurosurgery (2003) 1.13
Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J Virol (2012) 1.12
Varicella-zoster virus expression in the cerebral arteries of diabetic subjects. Arch Neurol (2012) 1.07
Varicella zoster virus latency, neurological disease and experimental models: an update. Front Biosci (2004) 1.07
Aberrant virion assembly and limited glycoprotein C production in varicella-zoster virus-infected neurons. J Virol (2013) 1.04
Simian varicella virus DNA is present and transcribed months after experimental infection of adult African green monkeys. J Neurovirol (2002) 1.04
Comparison of varicella-zoster virus RNA sequences in human neurons and fibroblasts. J Virol (2014) 1.03
Epigenetic regulation of varicella-zoster virus open reading frames 62 and 63 in latently infected human trigeminal ganglia. J Virol (2006) 1.02
Acute cerebellar ataxia in a 41 year old woman. Lancet Neurol (2006) 1.02
Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis. Ann Neurol (2009) 1.01
A cosmid-based system for inserting mutations and foreign genes into the simian varicella virus genome. J Virol Methods (2005) 1.01
Varicella-zoster virus human ganglionic latency: a current summary. J Neurovirol (2010) 1.01
The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Rep (2013) 0.98
T-cell infiltration correlates with CXCL10 expression in ganglia of cynomolgus macaques with reactivated simian varicella virus. J Virol (2012) 0.97
Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization. J Infect Dis (2011) 0.96
Molecular characterization of varicella zoster virus in latently infected human ganglia: physical state and abundance of VZV DNA, Quantitation of viral transcripts and detection of VZV-specific proteins. Curr Top Microbiol Immunol (2010) 0.94
Varicella zoster virus (VZV)-human neuron interaction. Viruses (2013) 0.93
Varicella zoster virus latency. Future Virol (2011) 0.93
Persistence of simian varicella virus DNA in CD4(+) and CD8(+) blood mononuclear cells for years after intratracheal inoculation of African green monkeys. Virology (2002) 0.93
T-Cell tropism of simian varicella virus during primary infection. PLoS Pathog (2013) 0.92
Varicella-zoster virus-induced apoptosis in MeWo cells is accompanied by down-regulation of Bcl-2 expression. J Neurovirol (2010) 0.92
Simian varicella virus induces apoptosis in monkey kidney cells by the intrinsic pathway and involves downregulation of bcl-2 expression. J Virol (2009) 0.91
Synthesis and decay of varicella zoster virus transcripts. J Neurovirol (2011) 0.89
Varicella-zoster virus trigeminal ganglioneuritis without rash. Neurology (2013) 0.89
Subclinical reactivation of varicella zoster virus in all stages of HIV infection. J Neurol Sci (2011) 0.88
Phosphorylation of the nuclear form of varicella-zoster virus immediate-early protein 63 by casein kinase II at serine 186. J Virol (2009) 0.88
Chronic active varicella zoster virus infection. Neurology (2012) 0.88
Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency. J Virol (2006) 0.86
Array analysis of simian varicella virus gene transcription in productively infected cells in tissue culture. J Virol (2005) 0.85
Simian varicella virus infection of Chinese rhesus macaques produces ganglionic infection in the absence of rash. J Neurovirol (2012) 0.85
Clinical and molecular aspects of varicella zoster virus infection. Future Neurol (2009) 0.84
Does apoptosis play a role in varicella zoster virus latency and reactivation? Viruses (2012) 0.83
Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63. J Gen Virol (2010) 0.83
Three-dimensional normal human neural progenitor tissue-like assemblies: a model of persistent varicella-zoster virus infection. PLoS Pathog (2013) 0.83
Search for varicella zoster virus DNA in saliva of healthy individuals aged 20-59 years. J Med Virol (2013) 0.82
T cells increase before zoster and PD-1 expression increases at the time of zoster in immunosuppressed nonhuman primates latently infected with simian varicella virus. J Neurovirol (2014) 0.82
Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH/gL complex and neutralizes VZV infection. J Virol (2012) 0.81
Rapid and sensitive detection of varicella zoster virus in saliva of patients with herpes zoster. J Virol Methods (2013) 0.81
Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia. J Neurovirol (2003) 0.81
Recombinant monoclonal antibody recognizes a unique epitope on varicella-zoster virus immediate-early 63 protein. J Virol (2012) 0.81
Robust pro-inflammatory and lesser anti-inflammatory immune responses during primary simian varicella virus infection and reactivation in rhesus macaques. J Neurovirol (2014) 0.80
In vitro antiviral activity of honey against varicella zoster virus (VZV): A translational medicine study for potential remedy for shingles. Transl Biomed (2012) 0.80
Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis (2012) 0.80